We are live on ! Find out more
PALI icon

Palisade Bio
PALI

9 hedge funds and large institutions have $35.5M invested in Palisade Bio in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

29% more funds holding

Funds holding: 7 → 9 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

8% less capital invested

Capital invested by funds: $38.8M → $35.5M (-$3.28M)

15% less call options, than puts

Call options by funds: $1.12M | Put options by funds: $1.31M

Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
–
Reduced
–
Closed
2
Calls
$1.12M
Puts
$1.31M
Net Calls
-$191K
Net Calls Change
-$347K

Top Buyers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
+$2.18M
2
Goldman Sachs
Goldman Sachs
New York
+$2.18M
3
Millennium Management
Millennium Management
New York
+$2.18M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.18M

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$4.36M
2
State Street
State Street
Massachusetts
-$2.18M
3
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$237K
4
Charles Schwab
Charles Schwab
California
-$192K
5
TA
Teachers Advisors
New York
-$183K
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
51
Guggenheim Capital
Illinois
$27K – – –
RCM
52
Rotella Capital Management
Washington
$25K – – –
Bank of America
53
Bank of America
North Carolina
$24K – – –
SG Americas Securities
54
SG Americas Securities
New York
$24K – – –
BIM
55
BlackRock Investment Management
Delaware
$23K – – –
TRCT
56
Tower Research Capital (TRC)
New York
$20K – – –
CFA
57
CT Financial Advisors
Pennsylvania
$20K – – –
MFS
58
MSI Financial Services
Massachusetts
$19K – – –
Simplex Trading
59
Simplex Trading
Illinois
$17K – – –
Deutsche Bank
60
Deutsche Bank
Germany
$11K – – –
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$8K – – –
Bank of Montreal
62
Bank of Montreal
Ontario, Canada
$6K – – –
TWA
63
TCI Wealth Advisors
Arizona
$5K – – –
NC
64
NewSquare Capital
Pennsylvania
$4K – – –
GWS
65
Glassman Wealth Services
Virginia
$3K – – –
BCMIO
66
Beacon Capital Management Inc (Ohio)
Ohio
$2K – – –
FNBT
67
FineMark National Bank & Trust
Florida
$1K – – –
HF
68
Hoxton Financial
West Virginia
$1K – – –
FHC
69
First Heartland Consultants
Missouri
$19 – – –
Manulife (Manufacturers Life Insurance)
70
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$6 – – –
AllianceBernstein
71
AllianceBernstein
Tennessee
– -$63K – –
Barclays
72
Barclays
United Kingdom
– -$1K – –
BlackRock
73
BlackRock
New York
– -$3K – –
BNP Paribas Financial Markets
74
BNP Paribas Financial Markets
France
– -$3.15K – –
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
– -$237K – –
1 2
3
4

PALI Hedge Fund Activity: Q2 2015 in Review

9 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2015, worth a combined $35.5M — down 8.4% from $38.8M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new PALI positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Credit Suisse, opening a new position worth an estimated $2.18M. The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $4.36M sold.

  • 9 institutional investors held Palisade Bio (PALI) as of Q2 2015, up from 7 in Q1 2015.
  • Funds reported $35.5M of Palisade Bio stock for Q2 2015, down 8.4% quarter-over-quarter.
  • 4 funds opened new Palisade Bio positions in Q2 2015 and 2 closed out, a net change of +2 holders.
  • The largest Palisade Bio buyer in Q2 2015 was Credit Suisse, an estimated $2.18M added.
  • The largest Palisade Bio seller in Q2 2015 was BlackRock Fund Advisors, an estimated $4.36M sold.

Based on aggregated 13F filings for Q2 2015.